DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

BACKGROUND: Current clinical guidelines suggest that breast cancers with low hormone receptor expression (LowHR) in 1–10% of tumor cells should be regarded as hormone receptor positive. However, clinical data show that these patients have worse outcome compared to patients with hormone receptor expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurmeister, Philipp, Weber, Karsten, Villegas, Sonia, Karn, Thomas, Untch, Michael, Thieme, Anne, Müller, Volkmar, Taube, Eliane, Fasching, Peter, Schmitt, Wolfgang D., Marmé, Frederik, Stickeler, Elmar, Sinn, Bruno V., Jank, Paul, Schem, Christian, Klauschen, Frederick, van Mackelenbergh, Marion, Denkert, Carsten, Loibl, Sibylle, Capper, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489064/
https://www.ncbi.nlm.nih.gov/pubmed/34602069
http://dx.doi.org/10.1186/s13148-021-01176-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489064/
https://www.ncbi.nlm.nih.gov/pubmed/34602069
http://dx.doi.org/10.1186/s13148-021-01176-5

Ejemplares similares